Palisade Bio, Inc. (PALI) stock
PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$0.94−0.07 (-6.72%)
Close on Nov 18, 2026Market cap $164.18MP/E –Yield –
Palisade Bio total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Palisade Bio's total debt was $87.00K at Dec 31, 2021. For fiscal 2021 it was $87.00K, down 92.4% from the year before. The highest annual figure on record is $8.79M in fiscal 2014.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $87.00K | -92.4% |
| FY2020 | Dec 31, 2020 | $1.14M | -69.2% |
| FY2016 | Dec 31, 2016 | $3.71M | -53.3% |
| FY2015 | Dec 31, 2015 | $7.93M | -9.8% |
| FY2014 | Dec 31, 2014 | $8.79M | +14.1% |
| FY2013 | Dec 31, 2013 | $7.70M | – |
| FY2012 | Dec 31, 2012 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2021 | Dec 31, 2021 | $87.00K | -96.6% |
| Q3 FY2021 | Sep 30, 2021 | $568.00K | -84.7% |
| Q2 FY2021 | Jun 30, 2021 | $1.14M | -76.4% |
| Q4 FY2020 | Dec 31, 2020 | $1.14M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.53M | – |
| Q4 FY2016 | Dec 31, 2016 | $3.71M | – |
| Q3 FY2016 | Sep 30, 2016 | $4.83M | – |
See a number that looks wrong?